MA71401A - 5h-pyrrolo[2,3-d]pyrimidine-6(7h)-one, et cristaux de sel de celui-ci - Google Patents
5h-pyrrolo[2,3-d]pyrimidine-6(7h)-one, et cristaux de sel de celui-ciInfo
- Publication number
- MA71401A MA71401A MA71401A MA71401A MA71401A MA 71401 A MA71401 A MA 71401A MA 71401 A MA71401 A MA 71401A MA 71401 A MA71401 A MA 71401A MA 71401 A MA71401 A MA 71401A
- Authority
- MA
- Morocco
- Prior art keywords
- pyrrolo
- pyrimidine
- salt crystals
- crystals
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022108654 | 2022-07-05 | ||
| PCT/JP2023/024703 WO2024009977A1 (fr) | 2022-07-05 | 2023-07-04 | ５ｈ－pyrrolo［２，３－ｄ］pyrimidine－６（７ｈ）－one, et cristaux de sel de celui-ci |
| EP23835509.3A EP4553078A1 (fr) | 2022-07-05 | 2023-07-04 | 5h-pyrrolo[2,3-d]pyrimidine-6(7h)-one, et cristaux de sel de celui-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA71401A true MA71401A (fr) | 2025-04-30 |
Family
ID=89453401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA71401A MA71401A (fr) | 2022-07-05 | 2023-07-04 | 5h-pyrrolo[2,3-d]pyrimidine-6(7h)-one, et cristaux de sel de celui-ci |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20260001883A1 (fr) |
| EP (1) | EP4553078A1 (fr) |
| JP (1) | JPWO2024009977A1 (fr) |
| CN (1) | CN119403807A (fr) |
| MA (1) | MA71401A (fr) |
| TW (1) | TW202421127A (fr) |
| WO (1) | WO2024009977A1 (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005117909A2 (fr) * | 2004-04-23 | 2005-12-15 | Exelixis, Inc. | Modulateurs des proteines kinases et leurs methodes d'utilisation |
| AR074072A1 (es) * | 2008-11-11 | 2010-12-22 | Lilly Co Eli | Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme |
| PT3459953T (pt) | 2016-05-20 | 2021-07-29 | Taiho Pharmaceutical Co Ltd | Novo derivado de 5h-pirrolo[2,3-d]pirimidin-6(7h)-ona |
-
2023
- 2023-07-04 WO PCT/JP2023/024703 patent/WO2024009977A1/fr not_active Ceased
- 2023-07-04 JP JP2024532139A patent/JPWO2024009977A1/ja active Pending
- 2023-07-04 MA MA71401A patent/MA71401A/fr unknown
- 2023-07-04 TW TW112124881A patent/TW202421127A/zh unknown
- 2023-07-04 EP EP23835509.3A patent/EP4553078A1/fr active Pending
- 2023-07-04 CN CN202380051803.7A patent/CN119403807A/zh active Pending
- 2023-07-04 US US18/880,293 patent/US20260001883A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN119403807A (zh) | 2025-02-07 |
| EP4553078A1 (fr) | 2025-05-14 |
| TW202421127A (zh) | 2024-06-01 |
| WO2024009977A1 (fr) | 2024-01-11 |
| JPWO2024009977A1 (fr) | 2024-01-11 |
| US20260001883A1 (en) | 2026-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200708524B (en) | Process for preparing pyrido[2,3-D]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one derivatives | |
| PL1761542T3 (pl) | Pochodne oktahydropirolo[3,4-c]pirolu i ich zastosowanie jako środków przeciwwirusowych | |
| EA201171243A1 (ru) | Производное бензодиазепина для лечения гематопоэтических новообразований и лейкоза | |
| PT1292591E (pt) | Derivados biciclicos substituidos para o tratamento de crescimento de celula anormal | |
| NO20053955D0 (no) | Pyrazolo [1,5-A] pyrimidinderivater | |
| DK1430057T3 (da) | Substituerede 2-pyridinyl-6,7,8, 9-tetrahydropyrimido [1,2-a] pyrimidin-4-on- og 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)onderivater | |
| NO20030033L (no) | Pyrido[2,3-D]pyrimidin- og pyrimido[4,5-D]pyrimidin- nukleosider | |
| ATE307815T1 (de) | Substituierte 2-pyrimidinyl-6,7,8,9- tetrahydropyrimido(1,2-a)pyrimidin-4-on- und 7- pyrimidinyl-2,3-dihydroimidazo(1,2-a)pyrimidin- 5(1h)onderivate gegen neurodegenerative erkrankungen | |
| EP3856743A4 (fr) | Composés imidazo [1, 2-a] pyridine et [1, 2, 4] triazolo [1, 5-a] pyridine substitués en tant qu'inhibiteurs de kinase ret | |
| ATE269333T1 (de) | 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2- a)pyrimidin-4-on- und 7-pyridinyl-2,3- dihydroimidazo(1,2-a)pyrimidin-5 1honderivate | |
| IL278875A (en) | Monohydrate and crystalline forms of 6-[(S4,S3)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo [5,1-A ]pyrazine-8-one | |
| ZA202100259B (en) | Pyrrolo[1,2-b]pyridazine derivatives | |
| DK8084D0 (da) | Heterocyclisk kondenserede pyrazolo (3,4-d)pyridin-3-oner samt deres fremstilling og anvendelse | |
| DK1543013T3 (da) | 5-[[(2,3-Diflourphenyl)methyl]-7-[[2-hydroxymethyl)-1-methylethyl]amino]thiazolo(4,5-d]pyrimidin-2(3H)-on, mononatriumsalt som CXCR2-antagonist | |
| EE200100377A (et) | Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena | |
| MA71401A (fr) | 5h-pyrrolo[2,3-d]pyrimidine-6(7h)-one, et cristaux de sel de celui-ci | |
| EP3459953A4 (fr) | Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one | |
| DK1678182T3 (da) | Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner | |
| SG11202103496VA (en) | 2,6-dimethyl-n-((pyridin-4-yl)methyl)imidazo[1,2-b]pyridazin-8-amine and 2,5-dimethyl-n-[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine derivatives for treating viral infections | |
| AU2019389262B2 (en) | 3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4H)-one derivatives | |
| CO5721004A2 (es) | Formas cristalinas novedosas de la sal de mesilato de 2,3-dimetil-8-(2,6-dimetilbencilamino)-n-hidroxietil-imidazol[1,2-a]piridin-6-carboxamida | |
| ZA202004972B (en) | 1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,3'-dione compounds as therapeutic agents activating tp53 | |
| FR2795731B1 (fr) | PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES | |
| HK1111364A (en) | Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives | |
| DK1259229T3 (da) | Anvendelse af benzo-thieno[2,3-d]pyrimidiner med PDE V-inhiberende virkning til behandling af erektil dysfunktion |